Rabigen SAG2
live vaccine against rabies
VIRBAC S.A.
1ère Avenue 2065m L.I.D. 06516 Carros
France
Rabigen SAG2 oral suspension, for red foxes and raccoon dogs.
Live attenuated rabies virus, SAG2 strain 8 log10 CCID50*/dose
* CCID50: Cell Culture Infective Dose 50%
Palatable matrix (bait) containing a tetracycline biomarker
For the active immunisation of red foxes and raccoon dogs to prevent infection by rabies virus. The duration of protection is of at least 6 months.
None.
No adverse events have been reported in the target species.
As this vaccine presentation contains traces of gentamicin and contains tetracycline as biomarker, occasional hypersensitivity reactions may be observed in domestic animals that have accidentally
ingested the bait.
Vomiting due to gastric intolerance (potentially due to the aluminium/PVC sachet as part of the bait vaccine), in dogs which have accidentally ingested the bait, has been reported.
Red foxes (Vulpes vulpes) and raccoon dogs (Nyctereutes procyonoides).
The intake of a single bait is sufficient to ensure active immunisation to prevent infection by rabies virus.
The baits are distributed by land or by air within the framework of vaccination campaigns against rabies. They are intended to be eaten by foxes / raccoon dogs.
The distribution rate depends on the topography and on the population of the target species. This minimum distribution rate is:
13 baits per square km over the areas where fox / raccoon dog density indexes were equal or
less than 3 foxes / raccoon dogs seen per 10 km.
20 baits per square km over the areas where fox / raccoon dog density indexes were more than 3 foxes / raccoon dogs seen per 10 km.
Baits shall not be distributed in inhabited areas, roads and watery areas.
Not applicable.
Keep out of the reach and sight of children Store in a freezer at -40°C to -20°C.
Protect from light. Keep the boxes tightly closed.
For animal treatment only.
It is recommended to wear rubber gloves.
People handling and distributing this vaccine should be vaccinated against rabies.
The safety of the vaccine in pregnant and lactating animals has not been investigated. However rabies virus and attenuated rabies vaccine viruses do not usually accumulate in reproductive organs and are not known to directly affect reproductive functions.
Immunocompromised/immunosuppressed individuals must not be allowed to handle this vaccine.
In the event of human exposure to the active ingredient of the vaccine, seek medical advice immediately and show the package leaflet or the label to the physician.
The import, sale, supply and/or use of this veterinary medicinal product is or may be prohibited in certain Member States on the whole or part of their territory pursuant to national animal health policy. Any person intending to import, sell, supply and/or use the veterinary medicinal product must consult the relevant Member State’s Competent Authority on the current vaccination policies prior to the import, sale, supply and/or use.
Restricted to duly designated competent administrative authorities.
Dispose of waste material and any unplaced baits at the end of the day of distribution by boiling or incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.
Detailed information on this product is available on the website of the European Medicines Agency
Not all pack sizes may be marketed.
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
VIRBAC BELGIUM N.V.
Esperantolaan 4 B-3001 Leuven
Tel: + 32 (0) 16 38 72 60
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC Danmark A/S
Profilvej 1
DK-6000 Kolding Tel: + 45 7552 1244
VIRBAC Tierarzneimittel GmbH Rögen 20
D-23843 Bad Oldesloe Tel: 49 (4531) 805 111
OÜ ZOOVETVARU
Uusaru 5
ET -76505 Saue/Harjumaa, ESTONIA Tel: + 372 6 709 006
VIRBAC BELGIUM N.V.
Esperantolaan 4 B-3001 Leuven
Tel: + 32 (0) 16 38 72 60
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC NEDERLAND BV
Hermesweg 15
NL-3771 ND-Barneveld Tel: 31 (0) 342 427 127
Virbac Norge
c/o Premium Pet Products Vollaveien 20 A
0614 Oslo
Tel: + 47 98 25 57 13
VIRBAC Österreich GmbH
Hildebrandgasse 27 A-1180 Wien
Tel: 43 (0) 1 21 834 260
VIRBAC HELLAS A.E.
23 rd Klm National Road Athens-Lamia 145 65 Agios Stefanos
Athens - GREECE Tel: +30 210 6219520
VIRBAC ESPAÑA S.A.
Angel Guimera 179-181
ES-8950 Esplugues de Llobregat (Barcelona) Tél. : + 34 93 470 79 40
France VIRBAC France 13ème rue – L.I.D.
F-06517 Carros Cedex
VIRBAC
1ère avenue 2065 m LID 06516 Carros
France
Tel: + 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC SRL
Via Ettore Bugatti 15 I-20142 Milano
Tel: + 39 02 40 92 47 1
Panchris Feeds (Veterinary) Ltd
Industrial Area Aradippou, 7100, Larnaca, Cyprus Tel: +357 24813333
OÜ ZOOVETVARU
Uusaru 5
ET - 76505 Saue/Harjumaa, ESTONIA Tel: + 372 6 709 006
OÜ ZOOVETVARU
Uusaru 5
ET - 76505 Saue/Harjumaa, ESTONIA Tel: + 372 6 709 006
VIRBAC Sp. z o.o.
ul. Puławska 314
02-819 Warszawa
VIRBAC DE Portugal
LABORATÓRIOS LDA
Ed13-Piso 1- Esc.3 Quinta da Beloura
2710-693 Sintra
+ 351 219 245 020
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
Virbac Danmark A/S Filial Sverige, c/o Incognito AB,
Box 1027,
171 21 Solna
Tel: + 45 7552 1244
VIRBAC Ltd
UK-Suffolk IP30 9 UP Tel: 44 (0) 1359 243243
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: + 33 (0) 4 92 08 73 00
VIRBAC S.A.
1ère avenue 2065 m – L.I.D F-06516 Carros
Tel: + 33 (0) 4 92 08 73 00